Press releases
Cannasouth Research Shows Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain
A THREE-YEAR neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating neuropathic pain, which affects about 400,000 New Zealanders or 8 per cent of the country’s population.
